Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01861301 · OUTCOME

Association Between Baseline HGF, MET Gene Amplification, MET IHC and PFS

Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma · Source last updated 2016-10-24

This outcome was registered, but no numerical results were posted in the captured record.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
Baseline to 1 year

What was measured

Will be evaluated using the Cox regression model.

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
description
Will be evaluated using the Cox regression model.
reporting Status
NOT_POSTED
time Frame
Baseline to 1 year
title
Association Between Baseline HGF, MET Gene Amplification, MET IHC and PFS
type
OTHER_PRE_SPECIFIED

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice